Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Journal of Clinical Gastroenterology
|
December 27, 2024
Treatment and Survival Disparities in Asian Americans With Hepatocellular Carcinoma: The Need to Disaggregate a Diverse Cohort
Robert Hu, Xiaohan Ying, Nicole Ng, et al.
BMC Cancer
|
October 27, 2010
Comparison of darbepoetin alfa dosed weekly (QW) vs. extended dosing schedule (EDS) in the treatment of anemia in patients receiving multicycle chemotherapy in a randomized, phase 2, open-label trial
Lee Schwartzberg, Ronald Burkes, Barry Mirtsching, et al.
Frontiers in Urology
|
February 2, 2026
Demographic and prognostic landscape of upper urinary tract urothelial carcinoma: an analysis of a national cancer database
Beau Hsia, Mark Moroz, Ethan Sipes, et al.
The Journal of Laryngology and Otology
|
July 24, 2025
A Comprehensive Analysis of Socio-economic and Clinical Factors in Head and Neck Cancer Patients Receiving Robotic Surgery
Darby Keirns, Beau Hsia, Paula Valeria Guerra-Navarro, et al.
European Journal of Medical Research
|
January 5, 2024
Survival and treatment in older patients with ewing sarcoma: an analysis of the national cancer database
Marco Braaten, Jacob Braaten, Jasleen Chaddha, et al.
Annals of Medicine and Surgery (2012)
|
August 11, 2025
Radical nephrectomy vs. partial nephrectomy in T1-2, N0, M0 cystic renal cell carcinoma
Marco Braaten, Bob Weng, Reid Morrissey, et al.
American Journal of Ophthalmology
|
April 4, 2026
The Role of Geography in United States Retinoblastoma Care
Jainam Shah, Sachin Pathuri, Joshua Ong, et al.
The Oncologist
|
April 15, 2006
Darbepoetin alfa administered every three weeks is effective for the treatment of chemotherapy-induced anemia
Ralph Boccia, Imtiaz A Malik, Vinay Raja, et al.
Journal of Pediatric Hematology/Oncology
|
July 9, 2024
Racial Disparities in Treatment and Outcomes of Pediatric Hepatoblastoma
Taylor Billion, Marco Braaten, Eva Holland, et al.
World Journal of Nephrology
|
June 26, 2025
Survival and treatment of stage IV renal cell carcinoma in academic <i>vs</i> non-academic medical centers
Bob Weng, Marco Braaten, Jenna Lehn, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Journal of Clinical Gastroenterology
|
December 27, 2024
Treatment and Survival Disparities in Asian Americans With Hepatocellular Carcinoma: The Need to Disaggregate a Diverse Cohort
Robert Hu, Xiaohan Ying, Nicole Ng, et al.
BMC Cancer
|
October 27, 2010
Comparison of darbepoetin alfa dosed weekly (QW) vs. extended dosing schedule (EDS) in the treatment of anemia in patients receiving multicycle chemotherapy in a randomized, phase 2, open-label trial
Lee Schwartzberg, Ronald Burkes, Barry Mirtsching, et al.
Frontiers in Urology
|
February 2, 2026
Demographic and prognostic landscape of upper urinary tract urothelial carcinoma: an analysis of a national cancer database
Beau Hsia, Mark Moroz, Ethan Sipes, et al.
The Journal of Laryngology and Otology
|
July 24, 2025
A Comprehensive Analysis of Socio-economic and Clinical Factors in Head and Neck Cancer Patients Receiving Robotic Surgery
Darby Keirns, Beau Hsia, Paula Valeria Guerra-Navarro, et al.
European Journal of Medical Research
|
January 5, 2024
Survival and treatment in older patients with ewing sarcoma: an analysis of the national cancer database
Marco Braaten, Jacob Braaten, Jasleen Chaddha, et al.
Annals of Medicine and Surgery (2012)
|
August 11, 2025
Radical nephrectomy vs. partial nephrectomy in T1-2, N0, M0 cystic renal cell carcinoma
Marco Braaten, Bob Weng, Reid Morrissey, et al.
American Journal of Ophthalmology
|
April 4, 2026
The Role of Geography in United States Retinoblastoma Care
Jainam Shah, Sachin Pathuri, Joshua Ong, et al.
The Oncologist
|
April 15, 2006
Darbepoetin alfa administered every three weeks is effective for the treatment of chemotherapy-induced anemia
Ralph Boccia, Imtiaz A Malik, Vinay Raja, et al.
Journal of Pediatric Hematology/Oncology
|
July 9, 2024
Racial Disparities in Treatment and Outcomes of Pediatric Hepatoblastoma
Taylor Billion, Marco Braaten, Eva Holland, et al.
World Journal of Nephrology
|
June 26, 2025
Survival and treatment of stage IV renal cell carcinoma in academic <i>vs</i> non-academic medical centers
Bob Weng, Marco Braaten, Jenna Lehn, et al.
Page
of 4